[1] de Aguiar Vallim TQ, Tarling EJ, Ahn H, et al. MAFG is a transcriptional repressor of bile acid synthesis and metabolism. Cell Metab, 2015, 21:298-310.
[2] Li T, Chiang JY. Bile acid signaling in metabolic disease and drug ther-apy. Pharmacol Rev, 2014, 66:948-983.
[3] Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab, 2005, 2: 217-225.
[4] Pandak WM, Heuman DM, Hylemon PB, et al. Failure of intravenous infusion of taurocholate to down-regulate choles-terol 7 alpha-hydroxylase in rats with biliary fistulas. Gastroenterology, 1995, 108: 533-544.
[5] Schaap FG, van der Gaag NA, Gouma DJ, et al. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology, 2009, 49:1228-1235.
[6] David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature, 2014, 505:559-563.
[7] Sayin SI, Wahlstrom A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab, 2013, 17:225-235.
[8] Haeusler RA, Astiarraga B, Camastra S, et al. Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids. Diabetes, 2013, 62: 4184-4191. |
